AI Science Tracker
EN

Integrative analysis of programmed cell death pathways reveals prognostic biomarkers and immune infiltration signatures in coronary artery disease.

Patient Service Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China · 26 Sep 2025 · medicine

Discovery

Integrative analysis of programmed cell death pathways reveals prognostic biomarkers and immune infiltration signatures in coronary artery disease.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning analysis of coronary-artery-disease data identified the PCDscore and five core genes as prognostic biomarkers, alongside immune-infiltration signatures. These are retrospective, computational associations; they do not establish causal gene function or clinical utility.

Technology: Machine-learning feature analysis identifies a programmed-cell-death-related prognostic score (PCDscore), five core genes and associated immune-infiltration signatures.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning feature analysis identifies a programmed-cell-death-related prognostic score (PCDscore), five core genes and associated immune-infiltration signatures.
Test and result
Europe PMC abstract reports the prognostic score, five core genes and immune-infiltration analysis in the study datasets; this is retrospective biomarker analysis.
Limitation / still unknown
Prospective clinical utility and causal roles of the identified genes were not established
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12557709/ · https://pubmed.ncbi.nlm.nih.gov/41158406/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.